- Patient Information:
Details with Side Effects
Overdosage with antimuscarinic agents, including Enablex, can result in severe antimuscarinic effects. Treatment should be symptomatic and supportive. In the event of overdosage, ECG monitoring is recommended. Enablex has been administered in clinical trials at doses up to 75 mg (five times the maximum therapeutic dose) and signs of overdose were limited to abnormal vision.
Enablex is contraindicated in patients with, or at risk for, the following conditions:
- urinary retention
- gastric retention, or
- uncontrolled narrow-angle glaucoma.
Last reviewed on RxList: 3/22/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Enablex Information
Enablex - User Reviews
Enablex User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.